FremantleMedia Acquires Majority Stake in Danish Drama Producer Miso
UPDATED: The RTL Group company behind the "Idol" and "X Factor" formats continues its push into scripted fare with the deal for the Scandinavian firm known for crime thriller "Those Who Kill."
LONDON -- FremantleMedia, the company behind such TV show formats as The X Factor, Idol and Got Talent, has agreed to acquire a majority stake in Danish drama production company Miso Film.
Continuing a recent push into scripted fare, FremantleMedia, part of Bertelsmann's RTL Group, will own a 51 percent stake. Financial details weren't disclosed. The company also has an option to raise its stake.
Miso, founded in 2004, focuses on primetime drama series and films. Among its productions are crime thriller Those Who Kill. A&E Networks is working on a U.S. remake, starring Chloe Sevigny and James D'Arcy.
Miso was founded by producer team Jonas Allen and Peter Bose.
"This is an important milestone in building our primetime scripted business and strengthening our position in the Scandinavian market," said Cecile Frot-Coutaz, CEO of FremantleMedia. "Jonas and Peter's talent and strong track record in producing high-end drama, together with their current slate, makes Miso Film a perfect fit for FremantleMedia and complements our existing high-end scripted business in the U.S., Germany and Australia."
Allen and Bose said: "Partnering with FremantleMedia is an important step forward in Miso Film's growth strategy. We strongly believe that FremantleMedia will be a key driver in Miso Film's further expansion in the Scandinavian market and release the full potential of the company's productions internationally."
Miso also is currently producing war drama series and film 1864, saying it is the largest production ever in Denmark.
On the big screen, Miso Film has produced thriller The Candidate and co-produced Norwegian World War II resistance drama Max Manus. Its releases have included English-language feature Ginger and Rosa. The firm's latest feature, Danny's Doomsday, is currently in postproduction with a planned theatrical release in the fall of 2014.